BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 350459)

  • 1. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
    Bullen AW; Losowsky MS
    Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reactivity in subjects remaining tuberculin-negative after repeated BCG vaccination.
    Szabó G; Szegedi G; Kovács L; Gergely P; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1976; 33(1):51-61. PubMed ID: 1023736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
    Repo H; Kostiala AA; Kosunen TU
    Clin Exp Immunol; 1980 Feb; 39(2):442-8. PubMed ID: 6993072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
    Isbister WH
    N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated response to BCG investigated by leukocyte migration test from an agarose droplet.
    Krystůfková O; Hausner P; Janatková I; Votava V; Sebes A
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):181-7. PubMed ID: 3411120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.
    Erard P
    Clin Exp Immunol; 1974 Nov; 18(3):439-48. PubMed ID: 4619978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the inhibition of leucocyte migration and monocyte spreading as in vitro assays for tuberculin hypersensitivity in man.
    Silobrcić V; Sabioncello A; Mazuran R; Dekaris D; Kadrnka-Lovrencić M
    Clin Exp Immunol; 1975 May; 20(2):239-47. PubMed ID: 813926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
    Hamasaki K
    Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of cellular sensitization to BCG and PPD using leukocyte cell migration inhibition].
    Lenzini L; Rottoli L; Rottoli P
    Ann Sclavo; 1975 SEP-OCT; 17(5):660-7. PubMed ID: 782381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The frequency profile of tuberculin skin testing among students in nursing school].
    Fujino T; Abe Y; Miyata A; Suzuki K
    Kekkaku; 1999 Jun; 74(6):493-7. PubMed ID: 10423960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte migration inhibition test in agarose: a method for the detection of cellular immunity in humans].
    Alkan SS
    Mikrobiyol Bul; 1976 Oct; 10(4):423-35. PubMed ID: 979705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanóva (Wari') Indians of Rondônia, south-western Brazilian Amazon.
    Escobar AL; Coimbra CE; Camacho LA; Santos RV
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):45-51. PubMed ID: 14974745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Examination of cell-mediated immunity using the leukocyte migration inhibition test in agarose].
    Zimmermann S; Felber F
    Z Gesamte Inn Med; 1977 Feb; 32(4):54-5. PubMed ID: 855396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of cellular immunity in clinically healthy children of parents with leprosy in northern Thailand.
    Nelson KE; Speck SM; Suprasert S; Smith T
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):147-53. PubMed ID: 6539306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of leucocyte migration inhibition test in coeliac disease. A reassessment using different gluten subfractions.
    Corazza GR; Rawcliffe PM; Frisoni M; Sarchielli P; Londei M; Campieri M; Lazzari R; Gasbarrini G
    Clin Exp Immunol; 1985 Apr; 60(1):117-22. PubMed ID: 4006297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modifying action of autologous blood serum in the leukocyte adherence inhibition test in stomach cancer].
    Kutrenkov OA; Miliukhina LM
    Vopr Onkol; 1984; 30(7):81-5. PubMed ID: 6380104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.